Skip to main content
CNTA logo
CNTA
(NASDAQ)
Centessa Pharmaceuticals plc
$39.69-- (--)
Loading... - Market loading

Centessa Pharmaceuticals (CNTA) Stock Price & Financial Analysis

Centessa Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$39.65 - $39.82
52-Week High$40.26
52-Week Low$9.60
Open$39.70
Volume3.65M
Average Volume (3M)3.65M
Market Cap5.32B
Shares Outstanding134.16M
Price to Sales (P/S)356.52
Price to Book (P/B)17.73
EV/EBITDA-23.79
Revenue (TTM)15.00M
Net Income (TTM)-242.70M
Free Cash Flow (TTM)-181.17M
EPS (TTM)$-1.81
Profit Margin-1617.99%
Operating Margin-1425.33%
Return on Equity (ROE)-80.48%
Debt to Equity0.37
50-Day MA$26.59
200-Day MA$22.44
52-Week Change201.28%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Centessa Pharmaceuticals

What is the current stock price for CNTA?

As of the latest trading session, CNTA stock trades at $39.69. The 52-week range is $9.60–$40.26, with a day range of $39.65–$39.82.

What is the P/E ratio for CNTA?

The P/E ratio (Price-to-Earnings) for CNTA is shown in the Key Statistics section. This valuation metric helps compare Centessa Pharmaceuticals plc to industry peers.

Does CNTA pay dividends?

Centessa Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CNTA?

Based on 5 analysts, the consensus for CNTA is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CNTA?

Centessa Pharmaceuticals's market capitalization is $5.32B, classifying it as a mid-cap company. Centessa Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.